The solar-powered, off-grid facility can store about 40 million vaccine doses, helping protect them from power outages.
The ambition highlights the need to strengthen Ethiopia’s local feed manufacturing capacity as poultry production expands.
The interim financing was oversubscribed with participation from private investors, family offices, and venture capital across the UK, Norway, and the European Union.
The funding will launch Maash’s French demo plant and support industrial-scale production of its LoCylia mycoprotein.
The project was officially opened on August 5, with representatives from Imas attending the ceremony.
Haid is investing in local production capacity in markets where livestock and aquaculture sectors are expanding.
The discussion focused on aquaculture, hatcheries, tuna fisheries, stock assessment and post-harvest technology.
The project will repurpose a 463,503-square-foot fermentation facility at ADM’s Clinton complex.
The acquisition gives BiomEdit control of Folium’s Guided Biotics CRISPR-Cas technology and BiomElix One.
The facility is expected to open by the end of 2026.